MedTrace Logo

New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy

NCT00283348 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2017-03-20

No results posted yet for this study

Summary

The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation and affects the function of the transplanted kidney. It is hoped that by studying blood, urine, and tissue samples of kidney transplant patients, new ways of diagnosing and treating CAN may be found.

Conditions

  • Chronic Rejection

Sponsors & Collaborators

  • Hoffmann-La Roche

    collaborator INDUSTRY

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Daniel G Maluf, MD · Virginia Commonwealth University

  • Valeria Mas, Ph.D. · Virginia Commonwealth University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00283348 on ClinicalTrials.gov